ArticleHypertension (Dallas, Tex. : 1979)2026
Impact of Preeclampsia Duration on Long-Term Cardiovascular Disease Risk.
Article in Hypertension (Dallas, Tex. : 1979), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Observational
- Article
- Phenotypic subclassification of preeclampsia through cluster analysis of preterm birth-related factors.BMC medical informatics and decision making · 2026Article
- Artificial intelligence for early prediction of gestational diabetes mellitus and preeclampsia: a systematic review of machine learning models and clinical decision support systems.Frontiers in artificial intelligence · 2026Review
- Hypertensive crisis in the critically ill.Annals of intensive care · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPreeclampsia is associated with increased risk of subsequent maternal cardiovascular diseases (CVD) compared with normotensive pregnancies. We examined whether a longer duration between preeclampsia diagnosis and delivery is associated with a higher CVD risk before age 55.
methodsNationwide health registry data from 2 Finnish cohorts were used: FINNPEC (n=1139) and FinnGen (n=3603). Exposure was the duration from preeclampsia diagnosis to delivery in days. Outcome was a composite CVD, including new-onset hypertensive diseases, ischemic heart diseases, cerebral/precerebral arterial diseases, and peripheral artery diseases diagnosed before age 55. Cox proportional hazards models were used to estimate the risk of composite CVD for each day between preeclampsia diagnosis and delivery.
resultsMedian follow-up time after delivery was 12.2 years (interquartile range, 11.0-15.5) in FINNPEC and 17.1 years (interquartile range, 12.5-22.2) in FinnGen. A longer preeclampsia duration was associated with elevated CVD risk on a daily basis, with a hazard ratio of 1.02 (95% CI, 1.00-1.04);
conclusionsLong-term CVD risk before age 55 is estimated to increase 1% to 2% per day from preeclampsia diagnosis to delivery. Women with preeclampsia might benefit from early delivery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.